Preview

Pediatric pharmacology

Advanced search

THE FIRST INTERNATIONAL MASTER-CLASS ON PAEDIATRIC VACCINES. RESULTS AND FUTURE TRENDS

Abstract

On July, 1–2 within the framework of the Europaediatrics-2009 congress took place the master — class on vaccination. This initiative was realized under the direction of the Union of Pediatricians of Russia, the East European Vaccine Advisory Group (EEVAG) and Hepatitis Prevention Board (HpB). This master-class was supported by GlaxoSmithKline Company — the world leader in vaccines manufacture. During this master-class leading Russian experts in the field of infectious diseases have presented the data of unique researches underlining the current urgency of infectious diseases, for the present not included in an obligatory part of the National immunization schedule of Russia — a hepatitis A and a chicken pox. Necessity of discussion of a problem of these infections at children also has been caused by the opinion (both among pediatricians, and among parents), that these infections do not represent serious danger to health of the child. Participants of this master — class were more than 30 experts — pediatricians, epidemiologists, immunologists, infectionists and organizers of public health services from not only different regions of Russia, but also the CIS countries — Kazakhstan, Belarus and Ukraine.

About the Author

L.S. Namazova-Baranova
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


Review

For citations:


Namazova-Baranova L. THE FIRST INTERNATIONAL MASTER-CLASS ON PAEDIATRIC VACCINES. RESULTS AND FUTURE TRENDS. Pediatric pharmacology. 2009;6(4):7-20.

Views: 457


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)